NPCE SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving NeuroPace

PR Newswire

NEW YORK, Nov. 17, 2026

NeuroPace forecast roughly 20% third-quarter RNS growth without referencing a sales-force restructuring or large-account disruptions, then cut its 2026 outlook. NPCE shareholders who lost money may have the right to seek recovery.

NEW YORK, Nov. 17, 2026 /PRNewswire/ -- On August 11, 2026, NeuroPace (NASDAQ: NPCE) told investors to expect third-quarter RNS revenue growth of approximately 20% year over year. Instead, third-quarter total revenue came in at $23.1 million, down 1.1%, 2026 revenue guidance was cut by about $9 million at the midpoint, and NPCE shares fell roughly 37% on November 13, 2026. If you owned NPCE stock when that outlook was reset, you may have the right to recover your losses. Shareholders who lost money on NPCE are encouraged to submit their NPCE losses for review now. You may also contact Joseph E. Levi, Esq. via email at jlevi@SueWallSt.com  or by telephone at (888) SueWallSt.

SueWallSt.com

The forecast came from Chief Financial Officer Patrick Williams on the second-quarter call: "We expect our third quarter RNS revenue growth to be similar to our first half RNS growth rate of approximately 20% year-over-year." On the same call, Chief Executive Officer Joel Becker said second-quarter performance "reflects continued momentum in the core RNS business and disciplined execution across the organization."

With third-quarter results, management lowered full-year 2026 revenue guidance to $91-$92 million from $99.5-$101.5 million. Among the factors cited were a sales-force restructuring and disruptions at several large customer accounts. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of NPCE shareholders, and investors may be eligible to participate whether or not they still hold their shares.

If you bought NeuroPace stock and are now holding a loss, find out if you can recover what you lost . Joseph E. Levi, Esq. can also be reached at jlevi@SueWallSt.com  or (888) SueWallSt.

WHY SUEWALLST : SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the NPCE Investigation

Q: Which statements are being investigated as potentially misleading?  A: The investigation concerns whether NeuroPace made materially false or misleading statements regarding its 2026 revenue outlook and expected third-quarter revenue growth. When the Company disclosed third-quarter revenue of $23.1 million and reduced full-year 2026 revenue guidance to $91-$92 million, the stock price declined.

Q: When did NeuroPace allegedly mislead investors?  A: The investigation concerns statements made before the corrective disclosure that allegedly caused investors to purchase securities at inflated prices. These include statements made on the Company's August 11, 2026 second-quarter earnings call, before NeuroPace reported its third-quarter results and lowered its 2026 guidance.

Q: Who is eligible to participate in the NPCE investigation?  A: Investors who purchased NPCE stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: What do NPCE investors need to do right now?  A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery . No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate?  A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if my NPCE losses are small -- is it still worth contacting a lawyer?  A: Yes. There is no minimum loss amount required to participate in the investigation.

Q: What does it cost me to participate?  A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.

Q: What if I live outside the United States?  A: U.S. securities investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 
jlevi@SueWallSt.com
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/npce-shareholder-investigation-suewallst-notifies-investors-of-potential-securities-claims-involving-neuropace-302941975.html

SOURCE SueWallSt.com